[1] |
Liu Yao, Feng Ying, Ren Jie, Wang Xianbo.
The influencing factors of abnormal liver function in patients with COVID-19 and its dynamic changes in different drug treatments
[J]. Journal of Capital Medical University, 2022, 43(3): 433-439.
|
[2] |
Geng Mingfan, Gao Fangyuan, Li Yuxin, Zhang Qun, Liu Yao, Wang Xianbo.
Antivirals therapy combined with traditional Chinese medicine effects on HBeAg seroconversion rate in patients with chronic hepatitis B
[J]. Journal of Capital Medical University, 2018, 39(6): 810-814.
|
[3] |
Wang Tiezheng, Wu Jushan, Meng Fankun, Zang Yunjin, Lin Dongdong, Li Jian, Li Ning.
Value of instantaneous elastic measurement on non invasive diagnosis of early hepatitis B -related liver cirrhosis
[J]. Journal of Capital Medical University, 2017, 38(2): 299-303.
|
[4] |
Fang Fang, Chen Kelin, Chen Yan, Huang Zeyu, Lyu Hong, Liu Shujing, Zhou Jin, Zhang Guojun, Kang Xixiong.
Evaluation of anti-interference capability of HBV DNA quantitative reagents according to CNAS CL-36 criterion
[J]. Journal of Capital Medical University, 2016, 37(4): 495-499.
|
[5] |
Xu Yuanlong, Yang Xiansan, Liu Kaiyan, Yi Yin, Li Qunhui, Huang Xiaojie, Guo Caiping, Wu Hao.
Prevalence of and associated factors for HIV and HBV infections among men who have sex with men in Beijing, China
[J]. Journal of Capital Medical University, 2014, 35(1): 96-100.
|
[6] |
HU Hong-ying;LIU Ying;YANG Jin-kui.
Clinical analysis of hepatitis B virus asymptomatic carriers with type 2 diabetes
[J]. Journal of Capital Medical University, 2011, 32(5): 602-604.
|
[7] |
ZHANG Ting;XU Qiang;YANG Zi-wei;JIANG Su-zhen;LU Feng-min;CHEN Xiang-mei;ZHUANG Hui.
Identification of integrated hepatitis B virus mutations inhepatocellular carcinoma
[J]. Journal of Capital Medical University, 2011, 32(3): 313-317.
|
[8] |
CHANG Lu-si;QIAO Yong;WEI Hong-lian;XIAO Fan;HAO Xiao-hua;ZHANG Ren-wen;CHENG Jun;WEI Hong-shan.
HBV-related gene c18orf54 cloning and preliminary function
[J]. Journal of Capital Medical University, 2011, 32(3): 318-323.
|
[9] |
ZHANG Xin#;WU Yan-ning#;ZHANG Da-ke;DONG Pei-ling;FAN Chun-lei;LI Lei;.
Mutation profiles of basic core promoter and precore and pres in patients with chronic hepatitis B virus infection and their clinical implications
[J]. Journal of Capital Medical University, 2011, 32(3): 324-330.
|
[10] |
ZHANG Gui-li;LI Qiang;LI You-sheng;TAN Li-jie;ZHANG Hong;LIU Li-hong.
Relationship between Serum Adiponectin Levels and Correlative Factors in Patients with Hepatitis B and Liver Cirrhosis
[J]. Journal of Capital Medical University, 2010, 31(6): 792-794.
|
[11] |
WANG Hui;JIA Ji-dong.
Natural History and Long-term Outcome of Chronic Hepatitis B Virus Infection
[J]. Journal of Capital Medical University, 2010, 31(5): 582-585.
|
[12] |
WU Xiao-ning;YOU Hong;WU Jin-zhao;WU Peng;CONG Rui;WANG Mei-juan;MA Jia-li;WANG Rui;OU Xiao-juan;JIA Ji-dong.
The Construction and Test of Clinical Web Information System and Sample Management System of Chronic Hepatitis B
[J]. Journal of Capital Medical University, 2010, 31(5): 578-581.
|
[13] |
OU Xiao-juan;WANG Xiao-ming;YOU Hong;JIA Ji-dong;WANG Yu;DUAN Wei-jia;LI Yi-mei;LI Jia;WANG Bao-en.
Four-year Efficacy and Safety of Adefovir Dipivoxil for the Treatment of Chronic Hepatitis B
[J]. Journal of Capital Medical University, 2010, 31(5): 570-572.
|
[14] |
YANG Ye;CHEN Jing-shou;OU Xiao-juan;JIA Ji-dong;YOU Hong.
Follow up Study of HBV-induced Decompensated Cirrhosis Treated with Nucleot(s)ide Analogues
[J]. Journal of Capital Medical University, 2010, 31(5): 573-577.
|
[15] |
REN Jiang-bo;WANG Yu;LI Hong-yi;SUN Shu-jie;MA Hong;JIA Ji-dong.
Pilot Study on the Adefovir Dipivoxil Monotherapy in Telbivudine Resistant Patients with Chronic Hepatitis B
[J]. Journal of Capital Medical University, 2010, 31(5): 566-569.
|